How frequently and how soon should we screen our patients for the presence of antimalarial retinopathy?

被引：12

作者：

Alarcón, GS ^{[1
]}

机构：

[1] Univ Alabama Birmingham, Birmingham, AL 35294 USA

来源：

ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 02期

关键词：

D O I：

10.1002/art.10054

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：561 / 561

页数：1

共 10 条

[1] Hydroxychloroquine retinopathy: is screening necessary? [J].

Blyth, C ;

Lane, C .

BRITISH MEDICAL JOURNAL, 1998, 316 (7133) :716-717

[2]

Don BF, 2000, J RHEUMATOL, V27, P2703

[3]

EASTERBROOK M, 1992, CAN J OPHTHALMOL, V27, P237

[4] Detection and prevention of maculopathy associated with antimalarial agents [J].

Easterbrook, M .

INTERNATIONAL OPHTHALMOLOGY CLINICS, 1999, 39 (02) :49-57

[5]

FALCONE PM, 1993, ANN OPHTHALMOL, V25, P385

[6] Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice [J].

Levy, GD ;

Munz, SJ ;

Paschal, J ;

Cohen, HB ;

Pince, KJ ;

Peterson, T .

ARTHRITIS AND RHEUMATISM, 1997, 40 (08) :1482-1486

[7] Retinal toxicity in long term hydroxychloroquine treatment [J].

Mavrikakis, M ;

Papazoglou, S ;

Sfikakis, PP ;

Vaiopoulos, G ;

Rougas, K .

ANNALS OF THE RHEUMATIC DISEASES, 1996, 55 (03) :187-189

[8]

Rynes RI, 1996, LUPUS, V5, pS73, DOI 10.1177/096120339600500117

[9]

RYNES RI, 1993, LUPUS S1, V2, P517

[10]

Simms RW, 1996, ARTHRITIS RHEUM-US, V39, P723

← 1 →